Balaxi Pharmaceuticals Limited (BALAXI.NS)

INR 79.69

(0.59%)

Total Debt Summary of Balaxi Pharmaceuticals Limited

Balaxi Pharmaceuticals Limited's latest annual total debt in 2023 was 176.61 Million INR , up 32.72% from previous year.
Balaxi Pharmaceuticals Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
Balaxi Pharmaceuticals Limited reported annual total debt of 133.06 Million INR in 2022, up 265.75% from previous year.
Balaxi Pharmaceuticals Limited reported annual total debt of 36.38 Million INR in 2021, down -0.58% from previous year.
Balaxi Pharmaceuticals Limited reported quarterly total debt of 176.61 Million INR for 2023 FY, up 32.72% from previous quarter.
Balaxi Pharmaceuticals Limited reported quarterly total debt of 176.61 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Balaxi Pharmaceuticals Limited (2023 - 2012)

Historical Annual Total Debt of Balaxi Pharmaceuticals Limited (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	176.61 Million INR	32.72%
2022	133.06 Million INR	265.75%
2021	36.38 Million INR	-0.58%
2020	36.59 Million INR	296.32%
2019	9.23 Million INR	188.62%
2018	3.19 Million INR	961.03%
2017	301.5 Thousand INR	5763.04%
2016	-5324.00 INR	-126.35%
2015	20.2 Thousand INR	-20.6%
2014	25.45 Thousand INR	-98.62%
2013	1.84 Million INR	12.96%
2012	1.63 Million INR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	- INR	-100.0%
2023 FY	176.61 Million INR	32.72%
2023 Q4	176.61 Million INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q2	187.33 Million INR	0.0%
2023 Q1	- INR	-100.0%
2022 FY	133.06 Million INR	265.75%
2022 Q4	133.06 Million INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	22.67 Million INR	0.0%
2022 Q1	- INR	-100.0%
2021 Q4	36.38 Million INR	0.0%
2021 FY	36.38 Million INR	-0.58%
2021 Q3	- INR	-100.0%
2021 Q2	11.03 Million INR	0.0%
2021 Q1	- INR	-100.0%
2020 Q3	- INR	0.0%
2020 Q4	36.59 Million INR	0.0%
2020 Q2	- INR	0.0%
2020 FY	36.59 Million INR	296.32%
2020 Q1	- INR	0.0%
2019 FY	9.23 Million INR	188.62%
2019 Q4	- INR	0.0%
2019 Q3	- INR	0.0%
2019 Q1	- INR	0.0%
2019 Q2	- INR	0.0%
2018 FY	3.19 Million INR	961.03%
2018 Q3	- INR	0.0%
2018 Q4	- INR	0.0%
2018 Q1	- INR	0.0%
2018 Q2	- INR	0.0%
2017 Q2	- INR	0.0%
2017 Q3	- INR	0.0%
2017 Q4	- INR	0.0%
2017 FY	301.5 Thousand INR	5763.04%
2017 Q1	- INR	100.0%
2016 Q3	- INR	-100.0%
2016 FY	-5324.00 INR	-126.35%
2016 Q4	-5324.00 INR	0.0%
2016 Q2	2.77 Million INR	0.0%
2016 Q1	- INR	-100.0%
2015 FY	20.2 Thousand INR	-20.6%
2015 Q4	20.2 Thousand INR	0.0%
2014 FY	25.45 Thousand INR	-98.62%
2014 Q4	25.45 Thousand INR	0.0%
2013 FY	1.84 Million INR	12.96%
2012 FY	1.63 Million INR	0.0%

Peer Total Debt Comparison of Balaxi Pharmaceuticals Limited

Name	Total Debt	Total Debt Difference